Nimbus Synergies

Nimbus Synergies, established in 2017 and based in Vancouver, Canada, is a venture capital firm specializing in early-stage health technology companies in British Columbia. It invests CAD 0.25 million to CAD 3 million per company, fostering growth and success by facilitating resource sharing, industry knowledge exchange, and strategic partnerships among its portfolio. As a key player in the province's technology industry, Nimbus aims to drive innovation and improve health outcomes through its investments.

Laura Cassin

Investment Associate

Jason Robertson

Co-Founder and Partner

17 past transactions

Variational AI

Seed Round in 2025
Variational AI is a biotechnology company that leverages advanced machine learning techniques to efficiently generate novel compounds optimized for multiple therapeutic properties. Focused on drug discovery, the company aims to address key challenges in the pharmaceutical industry, particularly those related to drug attrition and the likelihood of clinical success. Variational AI specializes in developing selective kinase inhibitors for solid tumor indications and has plans to expand its target classes. By collaborating with leading biopharmaceutical partners and building an internal pipeline, the company enables faster identification of drug-like molecules that are potent, selective, safe, and synthesizable. Its innovative approach aims to reduce the time necessary for molecular optimization and enhance the success rates of drug development.

EmergConnect

Seed Round in 2024
EmergConnect is a digital platform designed to enhance emergency care through patient self-assessment, registration, and personalized wait time predictions. By utilizing artificial intelligence that comprehends natural language, the platform simplifies the triage and registration processes, allowing patients to provide information in an easily understandable manner. This automation of clinical documentation not only improves patient throughput but also enhances clinical outcomes. EmergConnect’s technology enables accurate clinical predictions, identifies high-risk patients, and forecasts individualized wait times, ultimately empowering clinicians with crucial data to improve efficiency in emergency rooms and deliver better care to patients.

VitaminLab

Series A in 2023
VitaminLab is a biopharmaceutical company focused on delivering personalized vitamins and supplements tailored to individual health needs. By utilizing health histories, nutrient testing, and a proprietary matching algorithm, the company creates customized supplements that aim to enhance overall well-being. Founded by a team of pharmacists and healthcare professionals, VitaminLab emphasizes the use of all-natural ingredients, including beetroot, stevia, and prebiotics, to formulate its products. This innovative approach seeks to transform the supplement industry by providing consumers with solutions that address their unique biological and health profiles.

Arbutus Medical

Seed Round in 2023
Arbutus Medical Inc. is a Vancouver-based company that specializes in the development and manufacturing of surgical power tools for orthopedic surgeries. Founded in 2014, the company focuses on creating cost-effective and user-friendly devices, including its flagship orthopedic power tool system, which is designed to be affordable and accessible. Arbutus Medical aims to address the rising costs of healthcare by offering innovative solutions that enhance access to orthopedic surgery for millions of patients, particularly in low- and middle-income countries. Its product portfolio includes various tools and sterile-packed procedure kits, such as the HEX drill kit and PRO drill kit, which are utilized in North American trauma centers, veterinary hospitals, military deployments, and humanitarian missions. Through its commitment to "frugal innovation," Arbutus Medical seeks to improve surgical outcomes while reducing expenses for healthcare providers.

Sonic Incytes Medical

Series A in 2021
Sonic Incytes Medical Corp is a medical device company based in Vancouver, Canada, focused on developing handheld ultrasound solutions for the assessment and monitoring of chronic liver diseases. Incorporated in 2012, the company specializes in quantitative ultrasound technology that supports point-of-care diagnostics and procedure guidance. Its portable devices provide a non-invasive method for diagnosing liver diseases, particularly in quantifying fatty liver disease, thereby enhancing the standard of care provided by medical practitioners. The company's mission is to facilitate routine assessment and management of liver health with reliable diagnostic accuracy.

LifeBooster

Series A in 2021
LifeBooster is a pioneer in the field of enterprise health and safety, specializing in risk analytics and wearable Internet of Things technology. The company has developed Senz, a connected worker platform that predicts and models risks and exposures across an entire workforce, aimed at preventing workplace injuries, illnesses, and fatalities. By digitizing and automating risk assessment processes, Senz provides health and safety professionals with the tools they need for accurate evaluations and effective injury prevention. LifeBooster's approach has achieved significant success, reportedly reducing risks in the industrial sector by up to 80%. Collaborating with local and global leaders in the fields of health and safety, risk management, and workers' compensation, LifeBooster has established itself as a leading provider of innovative connected worker solutions, dedicated to ensuring worker safety and well-being.

Arbutus Medical

Seed Round in 2020
Arbutus Medical Inc. is a Vancouver-based company that specializes in the development and manufacturing of surgical power tools for orthopedic surgeries. Founded in 2014, the company focuses on creating cost-effective and user-friendly devices, including its flagship orthopedic power tool system, which is designed to be affordable and accessible. Arbutus Medical aims to address the rising costs of healthcare by offering innovative solutions that enhance access to orthopedic surgery for millions of patients, particularly in low- and middle-income countries. Its product portfolio includes various tools and sterile-packed procedure kits, such as the HEX drill kit and PRO drill kit, which are utilized in North American trauma centers, veterinary hospitals, military deployments, and humanitarian missions. Through its commitment to "frugal innovation," Arbutus Medical seeks to improve surgical outcomes while reducing expenses for healthcare providers.

LifeBooster

Seed Round in 2020
LifeBooster is a pioneer in the field of enterprise health and safety, specializing in risk analytics and wearable Internet of Things technology. The company has developed Senz, a connected worker platform that predicts and models risks and exposures across an entire workforce, aimed at preventing workplace injuries, illnesses, and fatalities. By digitizing and automating risk assessment processes, Senz provides health and safety professionals with the tools they need for accurate evaluations and effective injury prevention. LifeBooster's approach has achieved significant success, reportedly reducing risks in the industrial sector by up to 80%. Collaborating with local and global leaders in the fields of health and safety, risk management, and workers' compensation, LifeBooster has established itself as a leading provider of innovative connected worker solutions, dedicated to ensuring worker safety and well-being.

HeadCheck Health

Seed Round in 2019
HeadCheck Health is a digital health company specializing in concussion management technologies for sports organizations worldwide. It addresses the significant human impact and financial risks associated with concussions, which are increasingly uninsured due to policy exclusions. HeadCheck's suite of tools simplifies the execution and monitoring of concussion protocols, tailoring to specific sports and levels. It offers customized injury reports, manages return-to-play testing, facilitates stakeholder communication, and aims to reduce injury risks by providing insights for safer athletic environments.

ALAViDA

Venture Round in 2018
Alavida Health Ltd., based in Vancouver, Canada, specializes in digital health rehabilitation for alcohol and substance use addiction. The company's core offering is a digital platform that delivers evidence-based treatment programs, combining cognitive-behavioral therapy, motivational interviewing, and targeted pharmacotherapy, all guided by professional therapists.

HeadCheck Health

Convertible Note in 2018
HeadCheck Health is a digital health company specializing in concussion management technologies for sports organizations worldwide. It addresses the significant human impact and financial risks associated with concussions, which are increasingly uninsured due to policy exclusions. HeadCheck's suite of tools simplifies the execution and monitoring of concussion protocols, tailoring to specific sports and levels. It offers customized injury reports, manages return-to-play testing, facilitates stakeholder communication, and aims to reduce injury risks by providing insights for safer athletic environments.

ALAViDA

Venture Round in 2018
Alavida Health Ltd., based in Vancouver, Canada, specializes in digital health rehabilitation for alcohol and substance use addiction. The company's core offering is a digital platform that delivers evidence-based treatment programs, combining cognitive-behavioral therapy, motivational interviewing, and targeted pharmacotherapy, all guided by professional therapists.

Blue Mesa Health

Seed Round in 2018
Blue Mesa Health Inc. is a digital therapeutics company focused on diabetes prevention through its innovative platform, Transform. Founded in 2015 and based in New York, the company provides a comprehensive solution that combines health coaching, behavioral psychology, and technology to help individuals reverse prediabetes and manage their health. Transform offers a weight loss program and weekly lessons, delivering evidence-based behavioral interventions in a flexible format. The company's mission extends beyond the United States, as it has launched its services in Latin America and the Middle East, aiming to become a global leader in culturally diverse, technology-driven health solutions. Blue Mesa Health operates as a subsidiary of Virgin Pulse, Inc.

Claris Healthcare

Seed Round in 2017
Claris Healthcare Inc., founded in 2012 and based in Vancouver, Canada, specializes in a communication platform that empowers healthcare providers to manage patient care remotely. The platform caters to three care types: chronic, acute, and social care, facilitating effective monitoring and support for patients, particularly seniors. Claris offers solutions such as Claris Continuum for chronic disease patient engagement, Claris Companion for remote monitoring of aging individuals, and Claris Reflex for guiding rehabilitation post-acute interventions. These configurations require no on-site installation or training, enabling immediate deployment and ease of use. The platform aims to enhance patient satisfaction by streamlining communication with care providers, providing access to instructional resources, and delivering direct feedback on recovery progress. Claris Healthcare's flexible and configurable solutions offer various deployment options, from fully integrated kits to compatible personal devices, ensuring comprehensive care and support while maximizing reimbursement opportunities for providers.

Blue Mesa Health

Seed Round in 2017
Blue Mesa Health Inc. is a digital therapeutics company focused on diabetes prevention through its innovative platform, Transform. Founded in 2015 and based in New York, the company provides a comprehensive solution that combines health coaching, behavioral psychology, and technology to help individuals reverse prediabetes and manage their health. Transform offers a weight loss program and weekly lessons, delivering evidence-based behavioral interventions in a flexible format. The company's mission extends beyond the United States, as it has launched its services in Latin America and the Middle East, aiming to become a global leader in culturally diverse, technology-driven health solutions. Blue Mesa Health operates as a subsidiary of Virgin Pulse, Inc.

Torus Biomedical Solutions

Non Equity Assistance in 2016
Torus Biomedical Solutions specializes in developing advanced radiology technology aimed at enhancing orthopedic and spine surgical procedures. The company's innovative solutions transform existing X-ray imaging equipment into precise measurement tools, allowing orthopedic surgeons to assess alignments during operations more effectively. By addressing the challenges associated with the adoption of new technologies in the orthopedic field, Torus provides cost-effective point-of-care decision support that aims to improve surgical outcomes and minimize the financial burden of repeat surgeries. Overall, Torus Biomedical Solutions is committed to advancing surgical practices and improving patient care within the orthopedic domain.

SwitchBoard.com

Non Equity Assistance in 2016
Switchboard.com, established in 1996, is a pioneering online directory service that connects consumers with local businesses. It offers an extensive database of over 21 million business listings and 96 million individual listings across the U.S. The company's core business is providing local online advertising solutions and Internet-based yellow pages, facilitating interactions between consumers, merchants, and national advertisers. In 2015, Switchboard expanded its services to include fleet management and compliance solutions for the transportation industry, offering products such as electronic logging devices, fleet management software, trailer tracking, and weigh station bypass systems to help fleets maintain compliance with regulations and streamline operations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.